ARVATE, H. R. Major clinical outcomes of the action of the co-agonist tirzepatide to liraglutide and semaglutide in the treatment of obesity and type 2 diabetes mellitus: a systematic review. International Journal of Nutrology, [S. l.], v. 18, n. 1, 2025. DOI: 10.54448/ijn25102. Disponível em: https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/400. Acesso em: 19 apr. 2025.